Security key
641288105
NeuroPace Inc - Common Stock, $0.01 par value (NPCE)
CUSIP: 641288105
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 25,945,404
- Total 13F value
- $267,500,978
- Share change
- +3,427,984
- Put/Call ratio
- 108%
- SEC-reported price per share
- $10.31
- Number of holders
- 80
- Value change
- +$34,175,646
- Number of buys
- 42
- Number of sells
- 49
- Shares outstanding
- 34,087,924
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q3 2025
Institutions
80
Top holders
10
NPCE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
NeuroPace Inc SEC filings
NeuroPace Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 641288105
Recent filing periods:
Ownership snapshot
Top reported holders of NPCE - NeuroPace Inc - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Polar Capital Holdings Plc
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
3/4/5
Lead comparable stake: 9.1%
13D/G row: Polar Capital Holdings Plc
Showing 1-6 of 15 holder rows.
Quick read
Polar Capital Holdings Plc leads the comparable SEC ownership view at 9.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Polar Capital Holdings Plc
9.1%
Soleus Private Equity Fund I, L.P.
8.9%
MORGAN STANLEY
8.3%
Soleus Capital Master Fund, L.P.
7%
Kent Lake PR LLC
4.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Polar Capital Holdings Plc |
13D/G
|
9.1%
|
$34,534,675
2,972,003 shares
|
$0 | 31 Mar 2025 |
| Soleus Private Equity Fund I, L.P. |
13D/G
Guy Levy
|
8.9%
|
$30,496,537
2,957,957 shares
|
$0 | 30 Sep 2025 |
| MORGAN STANLEY |
13D/G
13F
Company
|
8.3%
|
$28,926,723
2,489,391 shares
|
$0 | 31 Dec 2024 |
| Soleus Capital Master Fund, L.P. |
13D/G
Soleus Capital Management, L.P.
|
7%
|
$23,545,122
2,303,828 shares
|
$0 | 30 Jun 2025 |
| Kent Lake PR LLC |
13D/G
13F
Company
|
4.9%
|
$17,227,289
1,482,555 shares
|
+$116,944 | 31 Dec 2024 |
| ORBIMED ADVISORS LLC |
3/4/5
13F
10%+ Owner · Company
|
9.5%
|
$51,616,892
3,238,199 shares
|
— | 14 May 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
80
Shares
25,945,404
Rows available
80
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
98
Q3 2025 holders
80
Holder diff
-18
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend